These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16123377)

  • 1. Antihypertensive treatment and sympathetic excitation.
    Malliani A; Montano N
    Hypertension; 2005 Sep; 46(3):e8; author reply e8. PubMed ID: 16123377
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent sympathetic activation during chronic antihypertensive therapy: a potential mechanism for long term morbidity?
    Fu Q; Zhang R; Witkowski S; Arbab-Zadeh A; Prasad A; Okazaki K; Levine BD
    Hypertension; 2005 Apr; 45(4):513-21. PubMed ID: 15738344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baroreflex failure.
    Heusser K; Tank J; Luft FC; Jordan J
    Hypertension; 2005 May; 45(5):834-9. PubMed ID: 15837841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Negrao CE; Negrao MV
    J Appl Physiol (1985); 2010 Dec; 109(6):2006. PubMed ID: 21188817
    [No Abstract]   [Full Text] [Related]  

  • 5. Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension.
    Grassi G; Seravalle G; Turri C; Bolla G; Mancia G
    Hypertension; 2003 Mar; 41(3):558-62. PubMed ID: 12623959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High muscle sympathetic nerve activity is associated with left ventricular dysfunction in treated hypertensive patients.
    de Souza SB; Rocha JA; Cuoco MA; Guerra GM; Ferreira-Filho JC; Borile S; Krieger EM; Bortolotto LA; Consolim-Colombo FM
    Am J Hypertens; 2013 Jul; 26(7):912-7. PubMed ID: 23475700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Zaloga GP; Lake CR; Coleman MD; Ziegler MG
    Fed Proc; 1984 Jan; 43(1):72-7. PubMed ID: 6317467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with losartan/hydrochlorothiazide for blood pressure reduction and goal attainment in a real-world clinical setting in Japan.
    Suzuki H; Shimada Y; Fujiwara K
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):237-44. PubMed ID: 23129531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic and baroreflex function in hypertension: implications for current and new drugs.
    Grassi G
    Curr Pharm Des; 2004; 10(29):3579-89. PubMed ID: 15579055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):1996-8; discussion 2016. PubMed ID: 20185633
    [No Abstract]   [Full Text] [Related]  

  • 11. [Imidazoline receptor agonists: are they actual today?].
    Nebieridze DV; Kamyshova TV
    Kardiologiia; 2012; 52(12):90-3. PubMed ID: 23237448
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension.
    Béchir M; Enseleit F; Chenevard R; Lüscher TF; Noll G
    Am J Cardiol; 2005 Jan; 95(1):129-31. PubMed ID: 15619411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebuttal from Esler, Lambert, and Schlaich.
    Esler M; Lambert E; Schlaich M
    J Appl Physiol (1985); 2010 Dec; 109(6):2000-1. PubMed ID: 21148350
    [No Abstract]   [Full Text] [Related]  

  • 14. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension and the sympathetic nervous system - recent developments in research and treatment].
    Grisk O
    Dtsch Med Wochenschr; 2009 Nov; 134(45):2289-93. PubMed ID: 19876804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of antihypertensive medication adherence on blood pressure control in hypertension: the COMFORT study.
    Matsumura K; Arima H; Tominaga M; Ohtsubo T; Sasaguri T; Fujii K; Fukuhara M; Uezono K; Morinaga Y; Ohta Y; Otonari T; Kawasaki J; Kato I; Tsuchihashi T;
    QJM; 2013 Oct; 106(10):909-14. PubMed ID: 23696676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Rohrwasser A
    J Appl Physiol (1985); 2010 Dec; 109(6):2007. PubMed ID: 21188818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.